High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells
Š Šimečková, Z Kahounová, R Fedr, J Remšík… - Scientific Reports, 2019 - nature.com
Skp2 is a crucial component of SCFSkp2 E3 ubiquitin ligase and is often overexpressed in
various types of cancer, including prostate cancer (PCa). The epithelial-to-mesenchymal …
various types of cancer, including prostate cancer (PCa). The epithelial-to-mesenchymal …
Inhibition of Skp2 suppresses the proliferation and invasion of osteosarcoma cells
L Ding, R Li, X Han, Y Zhou, H Zhang… - Oncology …, 2017 - spandidos-publications.com
Osteosarcoma (OS) is a common bone tumor that mainly affects children and young adults.
S-phase kinase‑associated protein 2 (Skp2) has been characterized to play a critical …
S-phase kinase‑associated protein 2 (Skp2) has been characterized to play a critical …
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression
Skp2 E3 ligase is overexpressed in numerous human cancers and plays a critical role in cell-
cycle progression, senescence, metabolism, cancer progression, and metastasis. In the …
cycle progression, senescence, metabolism, cancer progression, and metastasis. In the …
The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy
PL Nguyen, DI Lin, J Lei, M Fiorentino, E Mueller… - … Oncology: Seminars and …, 2011 - Elsevier
BACKGROUND: In several human cancers, overexpression of Skp2 (S-phase kinase
associated protein 2), which targets p27 for degradation, portends a poorer prognosis. We …
associated protein 2), which targets p27 for degradation, portends a poorer prognosis. We …
Skp2: a novel potential therapeutic target for prostate cancer
Z Wang, D Gao, H Fukushima, H Inuzuka, P Liu… - … et Biophysica Acta (BBA …, 2012 - Elsevier
Prostate cancer is the most frequently diagnosed tumor in men and the second most
common cause of cancer-related death for males in the United States. It has been shown …
common cause of cancer-related death for males in the United States. It has been shown …
[HTML][HTML] Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer
SKP2, an F-box protein of the SCF type of the E3 ubiquitin ligase complex, plays an
important function in driving tumorigenesis through the destruction of numerous tumor …
important function in driving tumorigenesis through the destruction of numerous tumor …
Skp2 and Slug are coexpressed in aggressive prostate cancer and inhibited by neddylation blockade
A Mickova, G Kharaishvili, D Kurfurstova… - International Journal of …, 2021 - mdpi.com
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men in
Western countries, and there is still an urgent need for a better understanding of PCa …
Western countries, and there is still an urgent need for a better understanding of PCa …
[HTML][HTML] Skp2 is associated with paclitaxel resistance in prostate cancer cells
Y Yang, Y Lu, L Wang, A Mizokami… - Oncology …, 2016 - spandidos-publications.com
Prostate cancer is the most commonly diagnosed tumor in men in the United States. Patients
with hormone-refractory prostate cancer are often treated with paclitaxel, but most of them …
with hormone-refractory prostate cancer are often treated with paclitaxel, but most of them …
Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma
Y Zhang, YS Zvi, B Batko, N Zaphiros, EF O'Donnell… - Scientific reports, 2018 - nature.com
Osteosarcoma (OS), the most common primary cancer of bone, exhibits a high propensity for
local invasion and distant metastasis. This study sought to elucidate the role of S phase …
local invasion and distant metastasis. This study sought to elucidate the role of S phase …
Serine protease inhibitor Kazal type 1 promotes epithelial–mesenchymal transition through EGFR signaling pathway in prostate cancer
C Wang, L Wang, B Su, N Lu, J Song, X Yang… - The …, 2014 - Wiley Online Library
BACKGROUND Overexpression of serine protease inhibitor Kazal type 1 (SPINK1) defines
an aggressive molecular subtype of ETS fusion‐negative prostate cancer (PCa) patients in …
an aggressive molecular subtype of ETS fusion‐negative prostate cancer (PCa) patients in …
相关搜索
- skp2 expression mesenchymal phenotype
- skp2 expression tumorigenic potential
- mesenchymal phenotype tumorigenic potential
- mesenchymal transition prostate cancer
- skp2 expression down regulation
- skp2 expression lung metastasis
- osteosarcoma cells inhibition of skp2
- neddylation blockade prostate cancer
- pharmacological inhibition prostate cancer